How Much Data Should You Include in a Patent Application?

Dec 17, 2014

In the life sciences and chemistry fields it is important to be aware that a perceived lack of data in a patent application can have an impact on the eventual scope of protection available. Chris Bond of Forresters explains that is often necessary to decide how much data to include in a patent application in support of the claimed utility, for example, a biological activity; too much data there shows an effect at the edges of a broad claim; too little is likely to make the claim vulnerable to attack under inventive step. ...

Read More

A Hard Pill to Swallow: Meeting the Needs of Modern Consumers

Dec 17, 2014

Confronted with the “patent cliff”, dwindling drug discovery success and a host of other challenges, pharmaceutical companies are being forced to reconsider how they can remain profitable. This includes looking to external experts to foster innovation and a move towards actively placing every need of the modern patient at the centre of their strategy. Dr Thomas Hein of Hermes Pharma analyses the results of a recent survey that revealed a number of clear trends, highlighting that approximately 50% of the population have difficulties swallowing tablets and capsules. ...

Read More

Cost Savings for Healthcare Estates: Delivered through Improved Waste Management

Dec 17, 2014

You only have to read a newspaper or turn on the news to see how the NHS is struggling to meet the balance between demand for healthcare services and funding. Tony Mottram of GPT Waste provides this white paper as a reference tool for healthcare estates managers and finance directors to demonstrate the opportunities for cost savings through the implementation of effective, improved waste management strategies. It is based on a simple example, a new approach and the impact it has had on a healthcare organisation’s bottom line. ...

Read More

“Personal Pill” Regulations: Current Landscape and Future Scenario

Dec 17, 2014

The rapidly-evolving science of pharmacogenetics brought in the amazing concept of “personalisation of medicines” also referred to as the “personal pill”. Balamuralidhara V., Blessy A. Daniel, T.M. Pramod Kumar and Pratik Thakkar of JSS College of Pharmacy, Mysore, India aim to showcase the potential of this “personal pill” to revolutionise drug discovery and development as the explosion of interest in pharmacogenomics raises a number of concerns in the regulatory environment. ...

Read More